Profil
Naren Vyavahare founded Elastrin Therapeutics, Inc., where he worked as Director & Chief Scientific Officer.
Aktive Positionen von Naren Vyavahare
| Unternehmen | Position | Beginn |
|---|---|---|
Elastrin Therapeutics, Inc.
 Elastrin Therapeutics, Inc. BiotechnologyHealth Technology Elastrin Therapeutics, Inc. is a biotech company based in Simpsonville, SC. Elastrin Therapeutics is developing novel therapies to reverse cardiovascular disease using a proprietary platform that targets and restores degraded elastin by removing harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting. The company's treatment, a nanoparticle that specifically targets elastin, is able to reverse calcification in the arteries and other tissues, providing a solution to heart disease, stroke, high blood pressure, COPD, and aneurysm. The company was founded by Mirko Stange, Douglas Mulhall, Naren Vyavahare, Charles D. Rice, Valentin Busch, and Markus Zils. The CEO is Matthias Breugelmans. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Elastrin Therapeutics, Inc.
Elastrin Therapeutics, Inc. BiotechnologyHealth Technology Elastrin Therapeutics, Inc. is a biotech company based in Simpsonville, SC. Elastrin Therapeutics is developing novel therapies to reverse cardiovascular disease using a proprietary platform that targets and restores degraded elastin by removing harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting. The company's treatment, a nanoparticle that specifically targets elastin, is able to reverse calcification in the arteries and other tissues, providing a solution to heart disease, stroke, high blood pressure, COPD, and aneurysm. The company was founded by Mirko Stange, Douglas Mulhall, Naren Vyavahare, Charles D. Rice, Valentin Busch, and Markus Zils. The CEO is Matthias Breugelmans. | Health Technology |
